
Loading, please wait...

Loading, please wait...

Clinicians are increasingly encountering patients particularly influenced by online trends regarding weight loss medications. A recent cross-sectional study investigated the semaglutide social media information available on popular platforms like TikTok and Bilibili. This research highlights an unchecked information environment that may lead to unsupervised use and a misunderstanding of clinical risks.
Researchers analyzed the top 100 videos from each platform using validated tools including the JAMA benchmark criteria and the DISCERN tool. Interestingly, the study found no statistically significant differences in quality scores between TikTok and Bilibili. However, the overall reliability remains a concern because many videos emphasize personal experience over evidence-based medical guidance.
The analysis further revealed that videos specifically produced by non-professional organizations achieved higher JAMA scores compared to individual creators. Consequently, while organizations provide more structured data, individual influencers often dominate engagement metrics despite lower reliability. Therefore, patients might prioritize relatable stories over safety profiles. In addition, within the Indian healthcare context, where generic semaglutide is gaining traction, these findings clearly underscore the need for clinician-led education.
No, most videos on TikTok and Bilibili exhibit suboptimal quality. While professional organizations provide better data, individual experiences often lack the clinical nuance required for safe treatment.
The primary risks primarily include self-medication, incorrect dosing, and a failure to understand serious side effects such as pancreatitis or gallbladder issues.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare consultation. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Zeng J et al. Quality and Reliability of Semaglutide-Related Short Videos on TikTok and Bilibili. Am J Health Promot. 2026 May 04. doi: 10.1177/08901171261447644. PMID: 42077173.
Song J et al. Quality and reliability of semaglutide content on different Chinese short video platforms. Front Public Health. 2026 Feb 24. doi: 10.3389/fpubh.2026.1750738.
Heiss R et al. Prescription Drug Content On Social Media Often Misleading. JAMA Network Open. 2026 Apr 11.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A cross-sectional study of 200 semaglutide videos on TikTok and Bilibili reveals suboptimal reliability and the risks of social media-driven self-medication...
4 months ago

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today